Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumoursC Bokemeyer, H J Schmoll, A Harstrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancerH Wilke, U Klaassen, W Achterrath, et al.
International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.
The Journal of Infusional Chemotherapy|July 1, 1996
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancerH Wilke, M Korn, U Vanhöfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagusA Harstrick, C Bokemeyer, P Preusser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinomaA Harstrick, H J Schmoll, C H Köhne-Wömpner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinomaA Harstrick, H J Schmoll, H Wilke, et al.
Cancer|July 1, 1993
Single-agent carboplatinum for advanced seminoma. A phase II studyH J Schmoll, A Harstrick, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adultsA Harstrick, C Bokemeyer, H J Schmoll, et al.
Seminars in Oncology|April 1, 1992
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancerH Wilke, M Stahl, H J Schmoll, et al.
Pageof 9